Differences in Drug Poisonings Among Those Who Identify as Transgender Compared to Cisgender: An Analysis of the Toxicology Investigators Consortium (ToxIC) Core Registry, United States 2017-2021.
Publication/Presentation Date
9-18-2024
Abstract
PURPOSE: In this manuscript, the abbreviation TG is defined as persons who identify as transgender, GNC is defined as persons who identify as gender nonconforming, and CG is defined as persons who identify as cisgender. TG and GNC (e.g., nonbinary), are those whose gender identity and sex assigned at birth do not align, as opposed to CG. This study describes drug poisonings among TG, GNC, and CG captured in the Toxicology Investigators Consortium (ToxIC) Core Registry during 2017-2021.
METHODS: Authors conducted a secondary data analysis of medical toxicology physician consultations involving intentional exposures (i.e., use with the knowledge of the exposed person) within the ToxIC Core Registry from 2017 through 2021. Demographic characteristics, exposure intent, and reported drug classes are reported by gender identity and sex assigned at birth.
FINDINGS: From a total of 15,800 medical toxicology consultations, 213 (1.3%) involved both TG (n = 187, 1.2%) and GNC (n = 26, 0.2%), and 15,587 (98.7%) involved CG. Among TG, 128 (68.8%) were transgender men, 58 (31.2%) transgender women. Sixty-two percent of TG/GNC (n = 132) and 34.8% of CG (n = 5,428) were aged ≤18 years. Reported intent for exposure (i.e., self-harm and misuse/harmful use) differed proportionally across both sexes assigned at birth and gender identity among transgender men and cisgender men.
IMPLICATIONS: In the ToxIC Core Registry, the consultations varied proportionally by age group across TG/GNC and CG, with more than half of TG/GNC aged ≤18 years. The proportion of consultations also varied by intent across TG/GNC and CG. Further research to delineate differences between TG/GNC and CG could increase knowledge in prevention, assessment, and treatment of drug poisonings in this population.
ISSN
1879-114X
Published In/Presented At
Magnusson, K., Glidden, E., Mustaquim, D., Welder, L. E., Stokes, E. K., Beauchamp, G. A., Greenberg, M. R., Aldy, K., Mazzaccaro, R. J., Careyva, B. A., Sabino, J. N., Fikse, D. J., McLain, K., Amaducci, A. M., & Toxicology Investigators Consortium (ToxIC) Study Group (2024). Differences in Drug Poisonings Among Those Who Identify as Transgender Compared to Cisgender: An Analysis of the Toxicology Investigators Consortium (ToxIC) Core Registry, United States 2017-2021. Clinical therapeutics, S0149-2918(24)00256-X. Advance online publication. https://doi.org/10.1016/j.clinthera.2024.08.018
Disciplines
Medicine and Health Sciences
PubMedID
39299811
Department(s)
Department of Emergency Medicine, Department of Emergency Medicine Faculty, Toxicology Division, Department of Family Medicine, Department of Pediatrics, USF-LVHN SELECT Program Faculty
Document Type
Article